Measurement of 6-oxo-PGF1α in human plasma using gas chromatography-mass spectrometry
Authors:
- C.N. HensbyCHC.N. Hensby
- G.A. FitzGeraldGFG.A. FitzGerald
- L.A. FriedmanLFL.A. Friedman
- P.J. LewisPLP.J. Lewis
- C.T. DolleryCDC.T. Dollery
- 1 November 1979
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 18 (5) , 731-736
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A double blind placebo controlled crossover study of prostacyclin in manLife Sciences, 1979
- The effects of indomethacin on arachidonic acid and prostaglandins e2 and f2alpha levels in human skin 24 h after u.v.B and u.v.C irradiation.British Journal of Clinical Pharmacology, 1978
- A sensitive radioimmunoassay for 6-keto-prostaglandin F1α: preliminary observations on circulating concentrationsProstaglandins and Medicine, 1978
- Metabolism of prostacyclin (PGI2)Prostaglandins, 1978
- Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acidProstaglandins, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- Preparative thin-layer and column chromatography of prostaglandinsJournal of Lipid Research, 1969